Deutsche Bank Maintains Hold on Agilon Health, Lowers Price Target to $4
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst George Hill maintains a Hold rating on Agilon Health (NYSE:AGL) but lowers the price target from $5 to $4.
August 09, 2024 | 4:56 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Deutsche Bank analyst George Hill maintains a Hold rating on Agilon Health (NYSE:AGL) and lowers the price target from $5 to $4.
The lowered price target from $5 to $4 by Deutsche Bank suggests a less optimistic outlook for Agilon Health, which could negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100